Scientific Opinion on Carbapenem resistance in food animal ecosystems

EFSA Journal

Volumn 11, Issue 12, 2013, Pages

[No Author Info available]

Author keywords

animals; carbapenemases occurrence; control options; detection; transmission

Indexed keywords

EID: 84963956874     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2013.3501     Document Type: Article

References (190)

1. Adler A, Navon-Venezia S, Moran-Gilad J, Marcos E, Schwartz D and Carmeli Y, 2011. Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs. Journal of clinical microbiology, 49, 2239–2242.
2. Adler A, Solter E, Masarwa S, Miller-Roll T, Abu-Libdeh B, Khammash H, Najem K, Dekadek S, Stein-Zamir C, Nubani N, Kunbar A, Assous MV, Carmeli Y and Schwaber MJ, 2013. Epidemiological and Microbiological Characteristics of an Outbreak Caused by OXA-48-Producing Enterobacteriaceae in a Neonatal Intensive Care Unit in Jerusalem, Israel. Journal of clinical microbiology, 51, 2926–2930.
3. Allen HK, Moe LA, Rodbumrer J, Gaarder A and Handelsman J, 2009. Functional metagenomics reveals diverse beta-lactamases in a remote Alaskan soil. ISME J, 3, 243–251.
4. Alvarado A, Pilar Garcillan-Barcia M and de la Cruz F, 2012. A Degenerate Primer MOB Typing (DPMT) Method to Classify Gamma-Proteobacterial Plasmids in Clinical and Environmental Settings. PloS one, 7.
5. Ambler RP, Coulson AFW, Frere JM, Ghuysen JM, Joris B, Forsman M, Levesque RC, Tiraby G and Waley SG, 1991. A standard numbering scheme for the class-A beta-lactamases. Biochemical Journal, 276, 269–270.
6. Anderson DJ, Engemann JJ, Harrell LJ, Carmeli Y, Reller LB and Kaye KS, 2006. Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae. Antimicrobial agents and chemotherapy, 50, 1715–1720.
7. Andrade LN, Curiao T, Ferreira JC, Longo JM, Climaco EC, Martinez R, Bellissimo-Rodrigues F, Basile-Filho A, Evaristo MA, Del Peloso PF, Ribeiro VB, Barth AL, Paula MC, Baquero F, Canton R, Darini AL and Coque TM, 2011. Dissemination of blaKPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in Brazil. Antimicrobial agents and chemotherapy, 55, 3579–3583.
8. Anthony F, Acar J, Franklin A, Gupta R, Nicholls T, Tamura Y, Thompson S, Threlfall EJ, Vose D, van Vuuren M and White DG, 2003. Antimicrobial resistance: responsible and prudent use of antimicrobial agents in veterinary medicine. In: OIE International Standards on Antimicrobial Resistance. OIE Headquarters, Paris, 2 to 4 October 2001. OIE publication with the participation of the OIE Collaborative Centre on Veterinary Medicinal Products, Fougères.
9. Arakawa Y, Shibata N, Shibayama K, Kurokawa H, Yagi T, Fujiwara H and Goto M, 2000. Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds. Journal of clinical microbiology, 38, 40–43.
10. Aubert D, Naas T, Heritier C, Poirel L and Nordmann P, 2006. Functional characterization of IS1999, an IS4 family element involved in mobilization and expression of beta-lactam resistance genes. J Bacteriol, 188, 6506–6514.
11. Aubron C, Poirel L, Ash RJ and Nordmann P, 2005. Carbapenemase-producing Enterobacteriaceae, U.S. rivers. Emerg Infect Dis, 11, 260–264.
12. Ben-David D, Maor Y, Keller N, Regev-Yochay G, Tal I, Shachar D, Zlotkin A, Smollan G and Rahav G, 2010. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol, 31, 620–626.
13. Bernabeu S, Poirel L and Nordmann P, 2012. Spectrophotometry-based detection of carbapenemase producers among Enterobacteriaceae. Diagnostic microbiology and infectious disease, 74, 88–90.
14. Bertini A, Poirel L, Mugnier PD, Villa L, Nordmann P and Carattoli A, 2010. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 54, 4168–4177.
15. Bogaerts P, Naas T, El Garch F, Cuzon G, Deplano A, Delaire T, Huang TD, Lissoir B, Nordmann P and Glupczynski Y, 2010. GES extended-spectrum beta-lactamases in Acinetobacter baumannii isolates in Belgium. Antimicrobial agents and chemotherapy, 54, 4872–4878.
16. Bogaerts P, Rezende de Castro R, de Mendonca R, Huang TD, Denis O and Glupczynski Y, 2013. Validation of carbapenemase and extended-spectrum beta-lactamase multiplex endpoint PCR assays according to ISO 15189. The Journal of antimicrobial chemotherapy.
17. Bonnin RA, Poirel L, Nordmann P, Eikmeyer FG, Wibberg D, Puhler A and Schluter A, 2013. Complete sequence of broad-host-range plasmid pNOR-2000 harbouring the metallo-beta-lactamase gene blaVIM-2 from Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 68, 1060–1065.
18. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B and Bartlett J, 2009. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis, 48, 1–12.
19. Burckhardt I and Zimmermann S, 2011. Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. Journal of clinical microbiology, 49, 3321–3324.
20. Bush K and Jacoby GA, 2010. Updated functional classification of beta-lactamases. Antimicrobial agents and chemotherapy, 54, 969–976.
21. Cabanes F, Lemant J, Picot S, Simac C, Cousty J, Jalin L, Naze F, Boisson V, Cresta MP, Andre H, Thibault L, Tixier F, Winer A, Antok E and Michault A, 2012. Emergence of Klebsiella pneumoniae and Salmonella Metallo-Beta-Lactamase (NDM-1) Producers on Reunion Island. Journal of clinical microbiology, 50, 3812–3812.
22. Canton R, Akova M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini GM, Samuelsen O, Seifert H, Woodford N, Nordmann P and European Network on C, 2012. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 18, 413–431.
23. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL and Threlfall EJ, 2005. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods, 63, 219–228.
24. Carattoli A, 2009. Resistance plasmid families in Enterobacteriaceae. Antimicrobial agents and chemotherapy, 53, 2227–2238.
25. Carattoli A, 2011. Plasmids in Gram negatives: molecular typing of resistance plasmids. Int J Med Microbiol, 301, 654–658.
26. Carattoli A, 2013. Plasmids and the spread of resistance. International Journal of Medical Microbiology, 303, 298–304.
27. Carrer A, Fortineau N and Nordmann P, 2010. Use of ChromID Extended-Spectrum beta-Lactamase Medium for Detecting Carbapenemase-Producing Enterobacteriaceae. Journal of clinical microbiology, 48, 1913–1914.
28. CDC (Centers for Disease Control and Prevention), 2012. Guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) - 2012 CRE toolkit. Available online: www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf
29. CDC (Centers for Disease Control and Prevention), 2013a. Antibiotic resistance threats in the United States, 2013. Available online: www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf
30. CDC (Centers for Disease Control and Prevention), 2013b. Vital signs: carbapenem-resistant Enterobacteriaceae. Morbidity and Mortality Weekly Report, 62, 165–170.
31. Chen J, Jin M, Qiu ZG, Guo C, Chen ZL, Shen ZQ, Wang XW and Li JW, 2012. A survey of drug resistance bla genes originating from synthetic plasmid vectors in six Chinese rivers. Environ Sci Technol, 46, 13448–13454.
32. Chitnis AS, Caruthers PS, Rao AK, Lamb J, Lurvey R, Beau De Rochars V, Kitchel B, Cancio M, Torok TJ, Guh AY, Gould CV and Wise ME, 2012. Outbreak of carbapenem-resistant enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions. Infect Control Hosp Epidemiol, 33, 984–992.
33. Chouchani C, Marrakchi R, Henriques I and Correia A, 2013. Occurrence of IMP-8, IMP-10, and IMP-13 metallo-beta-lactamases located on class 1 integrons and other extended-spectrum beta-lactamases in bacterial isolates from Tunisian rivers. Scandinavian journal of infectious diseases, 45, 95–103.
34. Chu YW, Cheung TK, Ngan JY and Kam KM, 2005. EDTA susceptibility leading to false detection of metallo-beta-lactamase in Pseudomonas aeruginosa by Etest and an imipenem-EDTA disk method. International journal of antimicrobial agents, 26, 340–341.
35. Ciobotaro P, Oved M, Nadir E, Bardenstein R and Zimhony O, 2011. An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice. Am J Infect Control, 39, 671–677.
36. CLSI (Clinical and Laboratory Standards Institute), 2008. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document M100-S18. Wayne, PA.
37. CLSI (Clinical and Laboratory Standards Institute), 2010. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI document M100-S20. Wayne, PA.
38. CLSI (Clinical and Laboratory Standards Institute), 2011. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. CLSI document M100-S21. Wayne, PA.
39. CLSI (Clinical and Laboratory Standards Institute), 2013. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. CLSI document M100-S23. Wayne, PA.
40. Cohen Stuart J, Leverstein-Van Hall MA and Dutch Working Party on the Detection of Highly Resistant M, 2010. Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae. International journal of antimicrobial agents, 36, 205–210.
41. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW and Carmeli Y, 2003. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis, 36, 53–59.
42. Cottell JL, Webber MA, Coldham NG, Taylor DL, Cerdeño-Tárraga AM, Hauser H, Thomson NR, Woodward MJ and Piddock LJ, 2011. Complete sequence and molecular epidemiology of Inck epidemic plasmid encoding blaCTX-M-14. Emerg Infect Dis, 17.
43. Dallenne C, Da Costa A, Decre D, Favier C and Arlet G, 2010. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. Journal of Antimicrobial Chemotherapy, 65, 490–495.
44. DANMAP (Danish Integrated Antimicrobial Resistance Monitoring and Research Programme), 2012. DANMAP 2012 - Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. Availabe online: www.danmap.org/Downloads/~/media/Projekt%20sites/Danmap/DANMAP%20reports/DANMAP%202012/Danmap_2012.ashx
45. Darley E, Weeks J, Jones L, Daniels V, Wootton M, MacGowan A and Walsh T, 2012. NDM-1 polymicrobial infections including Vibrio cholerae. Lancet, 380, 1358.
46. de Kraker ME, Wolkewitz M, Davey PG, Koller W, Berger J, Nagler J, Icket C, Kalenic S, Horvatic J, Seifert H, Kaasch A, Paniara O, Argyropoulou A, Bompola M, Smyth E, Skally M, Raglio A, Dumpis U, Melbarde Kelmere A, Borg M, Xuereb D, Ghita MC, Noble M, Kolman J, Grabljevec S, Turner D, Lansbury L and Grundmann H, 2011. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. The Journal of antimicrobial chemotherapy, 66, 398–407.
47. Dhanji H, Khan P, Cottell JL, Piddock LJV, Zhang J, Livermore DM and Woodford N, 2012. Dissemination of pCT-Like IncK Plasmids Harboring CTX-M-14 Extended-Spectrum -Lactamase among Clinical Escherichia coli Isolates in the United Kingdom. Antimicrobial agents and chemotherapy, 56, 3376–3377.
48. Di Pilato V, Pollini S and Rossolini GM, 2013. Characterization of plasmid pAX22, encoding VIM-1 metallo-β-lactamase, reveals a new putative mechanism of In70 integron mobilization. Journal of Antimicrobial Chemotherapy.
49. Didelot X, Bowden R, Wilson DJ, Peto TE and Crook DW, 2012. Transforming clinical microbiology with bacterial genome sequencing. Nat Rev Genet, 13, 601–612.
50. Docquier JD, Pantanella F, Giuliani F, Thaller MC, Amicosante G, Galleni M, Frere JM, Bush K and Rossolini GM, 2002. CAU-1, a subclass B3 metallo-beta-lactamase of low substrate affinity encoded by an ortholog present in the Caulobacter crescentus chromosome. Antimicrobial agents and chemotherapy, 46, 1823–1830.
51. ECDC, EFSA, EMEA and SCENHIR (European Centre for Disease Prevention and Control, European Food Safety Authority, European Medicines Agency and Scientific Committee on Emerging and Newly Identified Health Risks), 2009. Joint Opinion on antimicrobial resistance (AMR) focused on zoonotic infections. EFSA Journal 2009;7(11):1372, 78 pp. doi:10.2903/j.efsa.2009.1372. European Medicines Agency Reference EMEA/CVMP/447259/2009.
52. ECDC and EMEA (European Centre for Disease Prevention and Control and European Medicines Agency), 2009. The bacterial challenge: time to react. ECDC/EMEA Joint technical report. Available online: www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf
53. ECDC 2011. Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer. Available online: ecdc.europa.eu/en/publications/Publications/110913_Risk_assessment_resistant_CPE.pdf
54. ECDC 2012. Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Available online: www.ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51%2D4aed%2D4d32%2Db960%2Daf70113dbb90&ID=719&RootFolder=%2Fen%2Fpublications%2FPublications&Web=270275b7%2D419a%2D4352%2Da8fb%2Df0c757d92e66
55. EFSA (European Food Safety Authority), 2007. Report of the Task Force of Zoonoses Data Collection including a proposal for a harmonized monitoring scheme of antimicrobial resistance in Salmonella in fowl (Gallus gallus), turkeys, and pigs and Campylobacter jejuni and C. coli in broilers. The EFSA Journal 2007, 96, 1–46.
56. EFSA (European Food Safety Authority), 2008. Report from the Task Force on Zoonoses Data Collection including guidance for harmonized monitoring and reporting of antimicrobial resistance in commensal Escherichia coli and Enterococcus spp. from food animals. The EFSA Journal 2008, 141, 1–44.
57. EFSA (European Food Safety Authority), 2012a. Technical specifications on the harmonised monitoring and reporting of antimicrobial resistance in Salmonella, Campylobacter and indicator Escherichia coli and Enterococcus spp. bacteria transmitted through food. EFSA Journal 2012;10(6):2742, 64 pp. doi:10.2903/j.efsa.2012.2742
58. EFSA (European Food Safety Authority), 2012b. Technical specifications for the analysis and reporting of data on antimicrobial resistance in the European Union Summary Report. EFSA Journal 2012;10(2):2587, 53 pp. doi:10.2903/j.efsa.2012.2587
59. EFSA (European Food Safety Authority), 2012c. A pilot with volunteering reporting countries on submission of antimicrobial resistance isolate-based data in Excel and XML formats using the Data Collection Framework. Supporting Publications 2012: EN-220, 16 pp. Available online: www.efsa/europa.eu/publications
60. EFSA and ECDC (European Food Safety Authority and European Centre for Disease Prevention and Control), 2013. The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2011. EFSA Journal 2013;11(4):3129, 250 pp. doi:10.2903/j.efsa.2013.3129
61. EFSA Panel on Biological Hazards (BIOHAZ), 2011. Scientific Opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals. EFSA Journal 2011;9(8):2322, 95 pp. doi:10.2903/j.efsa.2011.2322
62. Endimiani A, Hujer KM, Hujer AM, Bertschy I, Rossano A, Koch C, Gerber V, Francey T, Bonomo RA and Perreten V, 2011. Acinetobacter baumannii isolates from pets and horses in Switzerland: molecular characterization and clinical data. The Journal of antimicrobial chemotherapy, 66, 2248–2254.
63. Fischer J, Rodriguez I, Schmoger S, Friese A, Roesler U, Helmuth R and Guerra B, 2012. Escherichia coli producing VIM-1 carbapenemase isolated on a pig farm. The Journal of antimicrobial chemotherapy, 67, 1793–1795.
64. Fischer J, Rodriguez I, Schmoger S, Friese A, Roesler U, Helmuth R and Guerra B, 2013a. Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farms. The Journal of antimicrobial chemotherapy, 68, 478–480.
65. Fischer J, Schmoger S, Baumann B, Laube H, von Salviati C, Friese A, Roesler U, Helmuth R and Helmuth BG, 2013b. Carbapenemases are present in enterobacteria from non-domestic animals…more frequently than we thought. In: Abstracts of the 23rd European Congress of Clinical Microbiology and Infectious Disease, ECCMID, Berlin, Germany. P1449. European Society for Clinical Microbiology and Infectious Disease, Basel, Switzerland.
66. Fischer J, Schmoger S, Jahn S, Helmuth R and Guerra B, 2013c. NDM-1 carbapenemase-producing Salmonella enterica subsp. enterica serovar Corvallis isolated from a wild bird in Germany. Journal of Antimicrobial Chemotherapy, 68, 2954–2956.
67. Fischer J, Schmoger S, Baumann B, Friese A, Roesler U, Helmuth R and Guerra B, 2013d. Carbapenemases are present in enterobacteria isolated from animals and the environment in livestock farms. In: Abstracts of the 66th Joint Annual Meeting of the German Society for Hygiene and Microbiology, DGHM, Rostock, Germany, September 2013. Abstract ZOV04. German Society for Hygiene and Microbiology, Hannover, Germany.
68. Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M and Fishman NO, 2009. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol, 30, 1180–1185.
69. Gijon D, Curiao T, Baquero F, Coque TM and Canton R, 2012. Fecal carriage of carbapenemase-producing Enterobacteriaceae: a hidden reservoir in hospitalized and nonhospitalized patients. Journal of clinical microbiology, 50, 1558–1563.
70. Girlich D, Poirel L and Nordmann P, 2010a. Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France. Antimicrobial agents and chemotherapy, 54, 328–332.
71. Girlich D, Poirel L and Nordmann P, 2010b. First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate. Antimicrobial agents and chemotherapy, 54, 578–579.
72. Girlich D, Poirel L and Nordmann P, 2011. Diversity of Clavulanic Acid-Inhibited Extended-Spectrum beta-Lactamases in Aeromonas spp. from the Seine River, Paris, France. Antimicrobial agents and chemotherapy, 55, 1256–1261.
73. Girlich D, Poirel L, Szczepanowski R, Schluter A and Nordmann P, 2012a. Carbapenem-hydrolyzing GES-5-encoding gene on different plasmid types recovered from a bacterial community in a sewage treatment plant. Applied and environmental microbiology, 78, 1292–1295.
74. Girlich D, Poirel L and Nordmann P, 2012b. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. Journal of clinical microbiology, 50, 477–479.
75. Girlich D, Anglade C, Zambardi G and Nordmann P, 2013a. Comparative evaluation of a novel chromogenic medium (chromID OXA-48) for detection of OXA-48 producing Enterobacteriaceae. Diagn Microbiol Infect Dis.
76. Girlich D, Poirel L and Nordmann P, 2013b. Comparison of the SUPERCARBA, CHROMagar KPC, and Brilliance CRE screening media for detection of Enterobacteriaceae with reduced susceptibility to carbapenems. Diagnostic microbiology and infectious disease, 75, 214–217.
77. Giske CG, Gezelius L, Samuelsen O, Warner M, Sundsfjord A and Woodford N, 2011. A sensitive and specific phenotypic assay for detection of metallo-beta-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 17, 552–556.
78. Gonzalez LJ and Vila AJ, 2012. Carbapenem resistance in Elizabethkingia meningoseptica is mediated by metallo-beta-lactamase BlaB. Antimicrobial agents and chemotherapy, 56, 1686–1692.
79. Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos J, Vatopoulos A, Gniadkowski M, Toth A, Pfeifer Y, Jarlier V, Carmeli Y and Group CW, 2010. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill, 15.
80. Guardabassi L, Dalsgaard A and Olsen JE, 1999. Phenotypic characterization and antibiotic resistance of Acinetobacter spp. isolated from aquatic sources. Journal of Applied Microbiology, 87, 659–667.
81. Gundogan N, Citak S and Yalcin E, 2011. Virulence properties of extended spectrum beta-lactamase-producing Klebsiella species in meat samples. Journal of food protection, 74, 559–564.
82. Gupta N, Limbago BM, Patel JB and Kallen AJ, 2011. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis, 53, 60–67.
83. Hamidian M, Hancock DP and Hall RM, 2013. Horizontal transfer of an ISAba125-activated ampC gene between Acinetobacter baumannii strains leading to cephalosporin resistance. The Journal of antimicrobial chemotherapy, 68, 244–245.
84. Hamouda A, Findlay J and Amyes SG, 2012. Imipenem resistance in Pseudomonas aeruginosa of animal origin. Journal of chemotherapy (Florence, Italy), 24, 59–60.
85. Hauser E, Tietze E, Helmuth R, Junker E, Prager R, Schroeter A, Rabsch W, Fruth A, Toboldt A and Malorny B, 2012. Clonal dissemination of Salmonella enterica serovar Infantis in Germany. Foodborne pathogens and disease, 9, 352–360.
86. Hendriksen RS, Vieira AR, Karlsmose S, Wong DMALF, Jensen AB, Wegener HC and Aarestrup FM, 2011. Global Monitoring of Salmonella Serovar Distribution from the World Health Organization Global Foodborne Infections Network Country Data Bank: Results of Quality Assured Laboratories from 2001 to 2007. Foodborne pathogens and disease, 8, 887–900.
87. Henriques IS, Araujo S, Azevedo JS, Alves MS, Chouchani C, Pereira A and Correia A, 2012. Prevalence and diversity of carbapenem-resistant bacteria in untreated drinking water in Portugal. Microbial drug resistance (Larchmont, N.Y.), 18, 531–537.
88. Hong SS, Kim K, Huh JY, Jung B, Kang MS and Hong SG, 2012. Multiplex PCR for rapid detection of genes encoding class A carbapenemases. Ann Lab Med, 32, 359–361.
89. Hrabak J, Walkova R, Studentova V, Chudackova E and Bergerova T, 2011. Carbapenemase activity detection by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Journal of clinical microbiology, 49, 3222–3227.
90. Ibrahim EH, Sherman G, Ward S, Fraser VJ and Kollef MH, 2000. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest, 118, 146–155.
91. Ikonomidis A, Ntokou E, Maniatis AN, Tsakris A and Pournaras S, 2008. Hidden VIM-1 metallo-beta-lactamase phenotypes among Acinetobacter baumannii clinical isolates. Journal of clinical microbiology, 46, 346–349.
92. Kaase M, Szabados F, Wassill L and Gatermann SG, 2012. Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR. Journal of clinical microbiology, 50, 3115–3118.
93. Karageorgopoulos DE, Miriagou V, Tzouvelekis LS, Spyridopoulou K and Daikos GL, 2012. Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases. The Journal of antimicrobial chemotherapy, 67, 2777–2779.
94. Kempf M, Rolain JM, Diatta G, Azza S, Samb B, Mediannikov O, Gassama Sow A, Diene SM, Fenollar F and Raoult D, 2012. Carbapenem resistance and Acinetobacter baumannii in Senegal: the paradigm of a common phenomenon in natural reservoirs. PloS one, 7, e39495.
95. Kim SH, Wei CI, Tzou YM and An H, 2005. Multidrug-resistant Klebsiella pneumoniae isolated from farm environments and retail products in Oklahoma. Journal of food protection, 68, 2022–2029.
96. Kimura S, Ishii Y and Yamaguchi K, 2005. Evaluation of dipicolinic acid for detection of IMP- or VIM-type metallo-beta-lactamase-producing Pseudomonas aeruginosa clinical isolates. Diagnostic microbiology and infectious disease, 53, 241–244.
97. Kotsakis SD, Petinaki E, Scopes E, Siatravani E, Miriagou V and Tzelepi E, 2013. Laboratory evaluation of Brilliance CRE agar for screening carbapenem-resistant Enterobacteriaceae: performance on a collection of characterised clinical isolates from Greece. J Global Antimicrob Resist, 1, 85–90.
98. Kristiansson E, Fick J, Janzon A, Grabic R, Rutgersson C, Weijdegard B, Soderstrom H and Larsson DG, 2011. Pyrosequencing of antibiotic-contaminated river sediments reveals high levels of resistance and gene transfer elements. PloS one, 6, e17038.
99. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM and Woodford N, 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. The Lancet infectious diseases, 10, 597–602.
100. Kumsa B, Socolovschi C, Parola P, Rolain JM and Raoult D, 2012. Molecular detection of acinetobacter species in lice and keds of domestic animals in oromia regional state, ethiopia. PloS one, 7, e52377.
101. Landman D, Salvani JK, Bratu S and Quale J, 2005. Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures. Journal of clinical microbiology, 43, 5639–5641.
102. Laube H, Friese A, von Salviati C, Guerra B, Kasbohrer A, Kreienbrock L and Roesler U, 2013a. Longitudinal Monitoring of Esbl/Ampc-Producing Escherichia Coli in German Broiler Chicken Fattening Farms. Applied and environmental microbiology.
103. Laube H, Friese A, von Salviati C, Guerra B, Käsbohrer A and Roesler U, 2013b. Emissions of ESBL/AmpC-producing E. coli from broiler and pig fattening farms in Germany. 5th Symposium on antimicrobial resistance in animals and the environment (ARAE) 2013, 30.6.13-3.7.13, Ghent, Belgium, page 50.
104. Lavilla S, Gonzalez-Lopez JJ, Miro E, Dominguez A, Llagostera M, Bartolome RM, Mirelis B, Navarro F and Prats G, 2008. Dissemination of extended-spectrum beta-lactamase-producing bacteria: the food-borne outbreak lesson. The Journal of antimicrobial chemotherapy, 61, 1244–1251.
105. Le Hello S, Harrois D, Bouchrif B, Sontag L, Elhani D, Guibert V, Zerouali K and Weill FX, 2013. Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study. Lancet Infectious Diseases, 13, 672–679.
106. Lee K, Chong Y, Shin HB, Kim YA, Yong D and Yum JH, 2001. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 7, 88–91.
107. Lee K, Lim YS, Yong D, Yum JH and Chong Y, 2003. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. Journal of clinical microbiology, 41, 4623–4629.
108. Liebana E, Batchelor M, Hopkins KL, Clifton-Hadley FA, Teale CJ, Foster A, Barker L, Threlfall EJ and Davies RH, 2006. Longitudinal farm study of extended-spectrum beta-lactamase-mediated resistance. Journal of clinical microbiology, 44, 1630–1634.
109. Liebana E, Carattoli A, Coque TM, Hasman H, Magiorakos A-P, Mevius D, Peixe L, Poirel L, Schuepbach-Regula G, Torneke K, Torren-Edo J, Torres C and Threlfall J, 2013. Public Health Risks of Enterobacterial Isolates Producing Extended-Spectrum beta-Lactamases or AmpC beta-Lactamases in Food and Food-Producing Animals: An EU Perspective of Epidemiology, Analytical Methods, Risk Factors, and Control Options. Clinical Infectious Diseases, 56, 1030–1037.
110. Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J and Woodford N, 2011. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. International journal of antimicrobial agents, 37, 415–419.
111. Loli A, Tzouvelekis LS, Gianneli D, Tzelepi E and Miriagou V, 2008. Outbreak of Acinetobacter baumannii with chromosomally encoded VIM-1 undetectable by imipenem-EDTA synergy tests. Antimicrobial agents and chemotherapy, 52, 1894–1896.
112. Magiorakos A-P, Suetens C, Monnet DL, Gagliotti C, Heuer OE, Group EA-NC and Participants EAN, 2013. The rise of carbapenem resistance in Europe: just the tip of the iceberg? Antimicrobial resistance and infection control, 2, 6–6.
113. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT and Monnet DL, 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 18, 268–281.
114. Maragakis LL, Perencevich EN and Cosgrove SE, 2008. Clinical and economic burden of antimicrobial resistance. Expert review of anti-infective therapy, 6, 751–763.
115. Marchaim D, Gottesman T, Schwartz O, Korem M, Maor Y, Rahav G, Karplus R, Lazarovitch T, Braun E, Sprecher H, Lachish T, Wiener-Well Y, Alon D, Chowers M, Ciobotaro P, Bardenstein R, Paz A, Potasman I, Giladi M, Schechner V, Schwaber MJ, Klarfeld-Lidji S and Carmeli Y, 2010. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Antimicrobial agents and chemotherapy, 54, 5099–5104.
116. Marchaim D, Chopra T, Pogue JM, Perez F, Hujer AM, Rudin S, Endimiani A, Navon-Venezia S, Hothi J, Slim J, Blunden C, Shango M, Lephart PR, Salimnia H, Reid D, Moshos J, Hafeez W, Bheemreddy S, Chen T-Y, Dhar S, Bonomo RA and Kaye KS, 2011. Outbreak of Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan. Antimicrobial agents and chemotherapy, 55, 593–599.
117. Miriagou V, Tzouvelekis LS, Rossiter S, Tzelepi E, Angulo FJ and Whichard JM, 2003. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrobial agents and chemotherapy, 47, 1297–1300.
118. Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M, Malamou-Lada E, Martinez-Martinez L, Navarro F, Nordmann P, Peixe L, Pournaras S, Rossolini GM, Tsakris A, Vatopoulos A and Canton R, 2010. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 16, 112–122.
119. Miriagou V, Tzelepi E, Kotsakis SD, Daikos GL, Bou Casals J and Tzouvelekis LS, 2013. Combined disc methods for the detection of KPC- and/or VIM-positive Klebsiella pneumoniae: improving reliability for the double carbapenemase producers. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
120. Moran Gilad J, Carmeli Y, Schwartz D and Navon-Venezia S, 2011. Laboratory evaluation of the CHROMagar KPC medium for identification of carbapenem-nonsusceptible Enterobacteriaceae. Diagnostic microbiology and infectious disease, 70, 565–567.
121. Munoz-Price LS and Weinstein RA, 2008. Acinetobacter infection. N Engl J Med, 358, 1271–1281.
122. Naas T, Bonnin RA, Cuzon G, Villegas MV and Nordmann P, 2013. Complete sequence of two KPC-harbouring plasmids from Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy.
123. Nawaz M, Khan SA, Tran Q, Sung K, Khan AA, Adamu I and Steele RS, 2012. Isolation and characterization of multidrug-resistant Klebsiella spp. isolated from shrimp imported from Thailand. Int J Food Microbiol, 155, 179–184.
124. Nordmann P, Cuzon G and Naas T, 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. The Lancet infectious diseases, 9, 228–236.
125. Nordmann P, Naas T and Poirel L, 2011a. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis, 17, 1791–1798.
126. Nordmann P, Poirel L, Walsh TR and Livermore DM, 2011b. The emerging NDM carbapenemases. Trends Microbiol, 19, 588–595.
127. Nordmann P, Girlich D and Poirel L, 2012a. Detection of Carbapenemase Producers in Enterobacteriaceae by Use of a Novel Screening Medium. Journal of clinical microbiology, 50, 2761–2766.
128. Nordmann P, Poirel L and Dortet L, 2012b. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis, 18, 1503–1507.
129. Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V and European Network on C, 2012c. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 18, 432–438.
130. Nordmann P and Poirel L, 2013. Strategies for identification of carbapenemase-producing Enterobacteriaceae. The Journal of antimicrobial chemotherapy, 68, 487–489.
131. Pasteran F, Mendez T, Guerriero L, Rapoport M and Corso A, 2009. Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. Journal of clinical microbiology, 47, 1631–1639.
132. Patel G, Huprikar S, Factor SH, Jenkins SG and Calfee DP, 2008. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol, 29, 1099–1106.
133. Patel G and Bonomo RA, 2013. “Stormy waters ahead”: global emergence of carbapenemases. Frontiers in microbiology, 4, 48.
134. Paterson DL and Bonomo RA, 2005. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev, 18, 657–686.
135. Pesapane R, Ponder M and Alexander KA, 2013. Tracking Pathogen Transmission at the Human-Wildlife Interface: Banded Mongoose and Escherichia coli. Ecohealth, 10, 115–128.
136. Pfeifer Y, Rabsch W, Höck M, Kuhns M, Werner G and Hunfeld KP, 2013. Emergence of OXA-48 and OXA-181 in Germany and in vivo plasmid transfer. In: Abstracts of the 23rd European Congress of Clinical Microbiology and Infectious Disease, ECCMID Berlin, Germany, P1274. European Society for Clinical Microbiology an Infectious Diseases, Basel, Switzerland.
137. Picao RC, Andrade SS, Nicoletti AG, Campana EH, Moraes GC, Mendes RE and Gales AC, 2008. Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. Journal of clinical microbiology, 46, 2028–2037.
138. Picao RC, Cardoso JP, Campana EH, Nicoletti AG, Petrolini FV, Assis DM, Juliano L and Gales AC, 2013. The route of antimicrobial resistance from the hospital effluent to the environment: focus on the occurrence of KPC-producing Aeromonas spp. and Enterobacteriaceae in sewage. Diagnostic microbiology and infectious disease, 76, 80–85.
139. Pires J, Novais A and Peixe L, 2013. Blue-CARBA: an easy biochemical 1 test to detect diverse carbapenemase producers directly from bacterial cultures. Published ahead of print 9 October 2013 doi:10.1128/JCM.01634-13. J Clin Microb.
140. Pitout JD, 2009. Recent changes in the epidemiology and management of extended-spectrum beta-lactamase-producing Enterobacteriaceae. F1000 medicine reports, 1.
141. Poirel L and Nordmann P, 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 12, 826–836.
142. Poirel L, Walsh TR, Cuvillier V and Nordmann P, 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagnostic microbiology and infectious disease, 70, 119–123.
143. Poirel L, Bercot B, Millemann Y, Bonnin RA, Pannaux G and Nordmann P, 2012a. Carbapenemase-producing Acinetobacter spp. in Cattle, France. Emerg Infect Dis, 18, 523–525.
144. Poirel L, Potron A and Nordmann P, 2012b. OXA-48-like carbapenemases: the phantom menace. The Journal of antimicrobial chemotherapy, 67, 1597–1606.
145. Quinteira S and Peixe L, 2006. Multiniche screening reveals the clinically relevant metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa far from the hospital setting: an ongoing dispersion process? Applied and environmental microbiology, 72, 3743–3745.
146. Rasheed JK, Kitchel B, Zhu W, Anderson KF, Clark NC, Ferraro MJ, Savard P, Humphries RM, Kallen AJ and Limbago BM, 2013. New Delhi metallo-beta-lactamase-producing Enterobacteriaceae, United States. Emerg Infect Dis, 19, 870–878.
147. Rhomberg PR and Jones RN, 2009. Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008). Diagnostic microbiology and infectious disease, 65, 414–426.
148. Roberts RR, Hota B, Ahmad I, Scott RD, 2nd, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB and Weinstein RA, 2009. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis, 49, 1175–1184.
149. Samra Z, Bahar J, Madar-Shapiro L, Aziz N, Israel S and Bishara J, 2008. Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae. Journal of clinical microbiology, 46, 3110–3111.
150. Savard P, Gopinath R, Zhu W, Kitchel B, Rasheed JK, Tekle T, Roberts A, Ross T, Razeq J, Landrum BM, Wilson LE, Limbago B, Perl TM and Carroll KC, 2011. First NDM-positive Salmonella sp. strain identified in the United States. Antimicrobial agents and chemotherapy, 55, 5957–5958.
151. Schechner V, Straus-Robinson K, Schwartz D, Pfeffer I, Tarabeia J, Moskovich R, Chmelnitsky I, Schwaber MJ, Carmeli Y and Navon-Venezia S, 2009. Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of the Enterobacteriaceae family. Journal of clinical microbiology, 47, 3261–3265.
152. Scotta C, Juan C, Cabot G, Oliver A, Lalucat J, Bennasar A and Alberti S, 2011. Environmental microbiota represents a natural reservoir for dissemination of clinically relevant metallo-beta-lactamases. Antimicrobial agents and chemotherapy, 55, 5376–5379.
153. Segal H and Elisha BG, 2005. Use of Etest MBL strips for the detection of carbapenemases in Acinetobacter baumannii. The Journal of antimicrobial chemotherapy, 56, 598.
154. Shaheen BW, Nayak R and Boothe DM, 2013. Emergence of a New Delhi Metallo-beta-Lactamase (NDM-1)-Encoding Gene in Clinical Escherichia coli Isolates Recovered from Companion Animals in the United States. Antimicrobial agents and chemotherapy, 57, 2902–2903.
155. Singh BR, Singh P, Agrawal S, Teotia U, Verma A, Sharma S, Chandra M, Babu N and Kant Agarwal R, 2007. Prevalence of multidrug resistant Salmonella in Coriander, mint, carrot, and radish in Bareilly and Kanpur, northern India. Foodborne pathogens and disease, 4, 233–240.
156. Singh S, Agarwal RK, Tiwari SC and Singh H, 2012. Antibiotic resistance pattern among the Salmonella isolated from human, animal and meat in India. Tropical animal health and production, 44, 665–674.
157. Smet A, Boyen F, Pasmans F, Butaye P, Martens A, Nemec A, Deschaght P, Vaneechoutte M and Haesebrouck F, 2012. OXA-23-producing Acinetobacter species from horses: a public health hazard? The Journal of antimicrobial chemotherapy, 67, 3009–3010.
158. Souli M, Galani I and Giamarellou H, 2008. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Eurosurveillance, 13, 19045.
159. Sousa C, Novais A, Magalhaes A, Lopes J and Peixe L, 2013. Diverse high-risk B2 and D Escherichia coli clones depicted by Fourier Transform Infrared Spectroscopy. Sci. Rep., 3.
160. Stephan R, Sarno E, Hofer E, Nueesch-Inderbinen MT and Haechler H, 2013. Lack of evidence so far for carbapenemase-producing Enterobacteriaceae in food-producing animals in Switzerland. Schweizer Archiv Fur Tierheilkunde, 155, 417–419.
161. Stokes MO, Cottell JL, Piddock LJV, Wu G, Wootton M, Mevius DJ, Randall LP, Teale CJ, Fielder MD and Coldham NG, 2012. Detection and characterization of pCT-like plasmid vectors for blaCTX-M-14 in Escherichia coli isolates from humans, turkeys and cattle in England and Wales. Journal of Antimicrobial Chemotherapy, 67, 1639–1644.
162. Stolle I, Prenger-Berninghoff E, Stamm I, Scheufen S, Hassdenteufel E, Guenther S, Bethe A, Pfeifer Y and Ewers C, 2013. Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs. Journal of Antimicrobial Chemotherapy, 68, 2802–2808.
163. Stuart JC, Voets G, Rottier W, Voskuil S, Scharringa J, Van Dijk K, Fluit AC and Leverstein-Van Hall M, 2013. Evaluation of the Oxoid Brilliance ™ CRE Agar for the detection of carbapenemase-producing Enterobacteriaceae. European Journal of Clinical Microbiology & Infectious Diseases, 32, 1445–1449.
164. Sypsa V, Psichogiou M, Bouzala G-A, Hadjihannas L, Hatzakis A and Daikos GL, 2012. Transmission Dynamics of Carbapenemase-Producing Klebsiella Pneumoniae and Anticipated Impact of Infection Control Strategies in a Surgical Unit. PloS one, 7.
165. Tello A, Austin B and Telfer TC, 2012. Selective pressure of antibiotic pollution on bacteria of importance to public health. Environ Health Perspect, 120, 1100–1106.
166. Tsakris A, Poulou A, Pournaras S, Voulgari E, Vrioni G, Themeli-Digalaki K, Petropoulou D and Sofianou D, 2010. A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates. The Journal of antimicrobial chemotherapy, 65, 1664–1671.
167. Tsakris A, Themeli-Digalaki K, Poulou A, Vrioni G, Voulgari E, Koumaki V, Agodi A, Pournaras S and Sofianou D, 2011. Comparative evaluation of combined-disk tests using different boronic acid compounds for detection of Klebsiella pneumoniae carbapenemase-producing enterobacteriaceae clinical isolates. Journal of clinical microbiology, 49, 2804–2809.
168. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT and Daikos GL, 2012. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev, 25, 682–707.
169. Valverde A, Canton R, Garcillan-Barcia MP, Novais A, Galan JC, Alvarado A, de la Cruz F, Baquero F and Coque TM, 2009. Spread of blaCTX-M-14 Is Driven Mainly by IncK Plasmids Disseminated among Escherichia coli Phylogroups A, B1, and D in Spain. Antimicrobial agents and chemotherapy, 53, 5204–5212.
170. Valverde A, Porrero C, Morosini MI, Dominguez L and Cantón R, 2012. Untreated wastewater urban effluents samples might act as a biosensor of environmental dissemination of carbapenemase producing Enterobacteriaceae: emergence of KPC-2 producers in Madrid, Spain. 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). London, 2012.
171. Viau RA, Hujer AM, Marshall SH, Perez F, Hujer KM, Briceno DF, Dul M, Jacobs MR, Grossberg R, Toltzis P and Bonomo RA, 2012. “Silent” dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in Northeast Ohio. Clin Infect Dis, 54, 1314–1321.
172. Vieira RH, Carvalho EM, Carvalho FC, Silva CM, Sousa OV and Rodrigues DP, 2010. Antimicrobial susceptibility of Escherichia coli isolated from shrimp (Litopenaeus vannamei) and pond environment in northeastern Brazil. J Environ Sci Health B, 45, 198–203.
173. Vieira RHSdF, Atayde MA, Carvalho EMRd, Carvalho FCTd and Fonteles Filho AA, 2008. Fecal contamination of the mangrove oyster Crassostrea rhizophorae and the cultivation water at the river pacoti estuary (Eusebio - Ceara State): identification and isolation of Escherichia coli and its susceptibility to different antimicrobians. Brazilian Journal of Veterinary Research and Animal Science, 45, 180–189.
174. Walsh TR, Toleman MA, Poirel L and Nordmann P, 2005. Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev, 18, 306–325.
175. Walsh TR, Weeks J, Livermore DM and Toleman MA, 2011. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. The Lancet infectious diseases, 11, 355–362.
176. Wang Y, Wu C, Zhang Q, Qi J, Liu H, Wang Y, He T, Ma L, Lai J, Shen Z, Liu Y and Shen J, 2012. Identification of New Delhi metallo-beta-lactamase 1 in Acinetobacter lwoffii of food animal origin. PloS one, 7, e37152.
177. WHO (World Health Organization), 2005. Critically important antibacterial agents for human medicine for risk management strategies of non-human use. Available online: whqlibdoc.who.int/publications/2005/9241593601_eng.pdf
178. WHO (World Health Organization), 2007. Critically important antimicrobials for human medicine: categorization for the development or risk management strategies to contain antimicrobial resistance due to non-human antimicrobial use. Available online: apps.who.int/iris/bitstream/10665/43765/1/9789241595742_eng.pdf
179. WHO (World Health Organization), 2011. Critically important antimicrobials for human medicine 2nd revision. Available online: apps.who.int/iris/bitstream/10665/77444/1/9789241501439_eng.pdf
180. WHO (World Health Organization), 2012. Critically important antimicrobials for human medicine 3rd revision 2011. Available online: apps.who.int/iris/bitstream/10665/77376/1/9789241504485_eng.pdf
181. Wilkinson KM, Winstanley TG, Lanyon C, Cummings SP, Raza MW and Perry JD, 2012. Comparison of Four Chromogenic Culture Media for Carbapenemase-Producing Enterobacteriaceae. Journal of clinical microbiology, 50, 3102–3104.
182. Woodford N, Warner M, Pike R and Zhang J, 2011. Evaluation of a commercial microarray to detect carbapenemase-producing Enterobacteriaceae. The Journal of antimicrobial chemotherapy, 66, 2887–2888.
183. Woodford N, Pike R, Meunier D, Loy R, Hill R and Hopkins KL, 2013a. In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase. Journal of Antimicrobial Chemotherapy.
184. Woodford N, Wareham DW, Guerra B and Teale C, 2013b. Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making? In press. Journal of Antimicrobial Chemotherapy.
185. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K and Tenover FC, 2001. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrobial agents and chemotherapy, 45, 1151–1161.
186. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM and Chong Y, 2002. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. Journal of clinical microbiology, 40, 3798–3801.
187. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM and Larsen MV, 2012. Identification of acquired antimicrobial resistance genes. The Journal of antimicrobial chemotherapy, 67, 2640–2644.
188. Zhang WJ, Lu Z, Schwarz S, Zhang RM, Wang XM, Si W, Yu S, Chen L and Liu S, 2013. Complete sequence of the blaNDM-1-carrying plasmid pNDM-AB from Acinetobacter baumannii of food animal origin. The Journal of antimicrobial chemotherapy.
189. Zhou Z, Du X, Wang L, Yang Q, Fu Y and Yu Y, 2011. Clinical carbapenem-resistant Acinetobacter baylyi strain coharboring blaSIM-1 and blaOXA-23 from China. Antimicrobial agents and chemotherapy, 55, 5347–5349.
190. Zurfluh K, Hachler H, Nuesch-Inderbinen M and Stephan R, 2013. Characteristics of extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae isolates from rivers and lakes in Switzerland. Applied and environmental microbiology, 79, 3021–3026.